[96a5a0]: / output / allTrials / identified / NCT01067976_identified.json

Download this file

590 lines (590 with data), 27.0 kB

  1
  2
  3
  4
  5
  6
  7
  8
  9
 10
 11
 12
 13
 14
 15
 16
 17
 18
 19
 20
 21
 22
 23
 24
 25
 26
 27
 28
 29
 30
 31
 32
 33
 34
 35
 36
 37
 38
 39
 40
 41
 42
 43
 44
 45
 46
 47
 48
 49
 50
 51
 52
 53
 54
 55
 56
 57
 58
 59
 60
 61
 62
 63
 64
 65
 66
 67
 68
 69
 70
 71
 72
 73
 74
 75
 76
 77
 78
 79
 80
 81
 82
 83
 84
 85
 86
 87
 88
 89
 90
 91
 92
 93
 94
 95
 96
 97
 98
 99
100
101
102
103
104
105
106
107
108
109
110
111
112
113
114
115
116
117
118
119
120
121
122
123
124
125
126
127
128
129
130
131
132
133
134
135
136
137
138
139
140
141
142
143
144
145
146
147
148
149
150
151
152
153
154
155
156
157
158
159
160
161
162
163
164
165
166
167
168
169
170
171
172
173
174
175
176
177
178
179
180
181
182
183
184
185
186
187
188
189
190
191
192
193
194
195
196
197
198
199
200
201
202
203
204
205
206
207
208
209
210
211
212
213
214
215
216
217
218
219
220
221
222
223
224
225
226
227
228
229
230
231
232
233
234
235
236
237
238
239
240
241
242
243
244
245
246
247
248
249
250
251
252
253
254
255
256
257
258
259
260
261
262
263
264
265
266
267
268
269
270
271
272
273
274
275
276
277
278
279
280
281
282
283
284
285
286
287
288
289
290
291
292
293
294
295
296
297
298
299
300
301
302
303
304
305
306
307
308
309
310
311
312
313
314
315
316
317
318
319
320
321
322
323
324
325
326
327
328
329
330
331
332
333
334
335
336
337
338
339
340
341
342
343
344
345
346
347
348
349
350
351
352
353
354
355
356
357
358
359
360
361
362
363
364
365
366
367
368
369
370
371
372
373
374
375
376
377
378
379
380
381
382
383
384
385
386
387
388
389
390
391
392
393
394
395
396
397
398
399
400
401
402
403
404
405
406
407
408
409
410
411
412
413
414
415
416
417
418
419
420
421
422
423
424
425
426
427
428
429
430
431
432
433
434
435
436
437
438
439
440
441
442
443
444
445
446
447
448
449
450
451
452
453
454
455
456
457
458
459
460
461
462
463
464
465
466
467
468
469
470
471
472
473
474
475
476
477
478
479
480
481
482
483
484
485
486
487
488
489
490
491
492
493
494
495
496
497
498
499
500
501
502
503
504
505
506
507
508
509
510
511
512
513
514
515
516
517
518
519
520
521
522
523
524
525
526
527
528
529
530
531
532
533
534
535
536
537
538
539
540
541
542
543
544
545
546
547
548
549
550
551
552
553
554
555
556
557
558
559
560
561
562
563
564
565
566
567
568
569
570
571
572
573
574
575
576
577
578
579
580
581
582
583
584
585
586
587
588
589
590
{
"info": {
"nct_id": "NCT01067976",
"official_title": "An Open Label, Multi-center, Phase 3 Study With Corresponding Blinded Image Reading to Determine the Efficacy and Safety of a Single Intravenous Injection of 0.1 mmol/kg Body Weight of Gadobutrol 1.0 Molar (Gadovist®) in Patients With Newly Diagnosed Breast Cancer Referred for Contrast-enhanced Breast MRI",
"inclusion_criteria": "* Recent histologically proven diagnosis of breast cancer after having obtained X-Ray Mammography (XRM) of both breasts (according to American College of Radiology [ACR] and performed no longer than 6 weeks prior to enrollment into the study) and has been referred for a contrast-enhanced Magnetic Resonance Mammography (MRM) prior to surgery of the breast.\n* If female, a digital XRM is required if any of the following criteria is met:\n\n 1. patient is younger than 50 years;\n 2. patient has heterogeneously or extremely dense breasts;\n 3. is not post-menopausal (post-menopause defined as at least 12 months prior to inclusion without menstruation).\n* If female of childbearing potential, MRM should be performed on the 7-14th day of the menstrual cycle.\n* Has an estimated glomerular filtration rate (eGFR) value >/= 60 mL/min/1.73m^2 derived from a serum creatinine result within 2 weeks prior to study enrollment.\nHealthy volunteers allowed\nMust have minimum age of 18 Years",
"exclusion_criteria": "* Is a female patient who is pregnant or lactating\n* Has any contraindication to the MRM examination (e.g. metal implants, phobia) or the use of gadolinium-containing contrast agents.\n* Has received any contrast agent within 24 hours prior to the study MRM, or is scheduled to receive any contrast agent within 24 hours after the study MRM.\n* Has severe cardiovascular disease (e.g., known long QT syndrome, acute myocardial infarction [< 14 days], unstable angina, congestive heart failure New York Heart Association class IV) or acute stroke (< 48 hours)).\n* Has acute renal insufficiency of any severity due to hepato-renal syndrome or in the peri-operative liver transplantation period or who has acute or chronic moderate or severe renal insufficiency (glomerular filtration rate < 60 mL/min/1.73m^2).\n* Has received chemotherapy or hormonal therapy for breast cancer within 6 months.\n* Has received hormone replacement therapy within 4 weeks prior to study drug administration.\n* Is scheduled or likely to require a surgery and/or biopsy in the time period up to 24 hours following study drug application\n* Has prior excisional biopsy or breast surgery less than 6 months before enrollment and between XRM and study MRM",
"miscellaneous_criteria": ""
},
"inclusion_lines": [
{
"line": "* Recent histologically proven diagnosis of breast cancer after having obtained X-Ray Mammography (XRM) of both breasts (according to American College of Radiology [ACR] and performed no longer than 6 weeks prior to enrollment into the study) and has been referred for a contrast-enhanced Magnetic Resonance Mammography (MRM) prior to surgery of the breast.",
"criterions": [
{
"exact_snippets": "Recent histologically proven diagnosis of breast cancer",
"criterion": "breast cancer diagnosis",
"requirements": [
{
"requirement_type": "recency",
"expected_value": "recent"
},
{
"requirement_type": "method",
"expected_value": "histologically proven"
}
]
},
{
"exact_snippets": "obtained X-Ray Mammography (XRM) of both breasts",
"criterion": "X-Ray Mammography",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
},
{
"requirement_type": "location",
"expected_value": "both breasts"
}
]
},
{
"exact_snippets": "according to American College of Radiology [ACR]",
"criterion": "X-Ray Mammography standard",
"requirements": [
{
"requirement_type": "standard",
"expected_value": "American College of Radiology [ACR]"
}
]
},
{
"exact_snippets": "performed no longer than 6 weeks prior to enrollment into the study",
"criterion": "X-Ray Mammography timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "weeks"
}
}
]
},
{
"exact_snippets": "referred for a contrast-enhanced Magnetic Resonance Mammography (MRM) prior to surgery of the breast",
"criterion": "Magnetic Resonance Mammography referral",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "prior to surgery"
}
]
}
]
},
{
"line": "* If female, a digital XRM is required if any of the following criteria is met:",
"criterions": [
{
"exact_snippets": "If female",
"criterion": "gender",
"requirements": [
{
"requirement_type": "value",
"expected_value": "female"
}
]
},
{
"exact_snippets": "a digital XRM is required",
"criterion": "digital XRM",
"requirements": [
{
"requirement_type": "requirement",
"expected_value": true
}
]
}
]
},
{
"line": "1. patient is younger than 50 years;",
"criterions": [
{
"exact_snippets": "patient is younger than 50 years",
"criterion": "age",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": "<",
"value": 50,
"unit": "years"
}
}
]
}
]
},
{
"line": "2. patient has heterogeneously or extremely dense breasts;",
"criterions": [
{
"exact_snippets": "heterogeneously or extremely dense breasts",
"criterion": "breast density",
"requirements": [
{
"requirement_type": "density",
"expected_value": [
"heterogeneously dense",
"extremely dense"
]
}
]
}
]
},
{
"line": "3. is not post-menopausal (post-menopause defined as at least 12 months prior to inclusion without menstruation).",
"criterions": [
{
"exact_snippets": "is not post-menopausal",
"criterion": "menopausal status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "not post-menopausal"
}
]
},
{
"exact_snippets": "post-menopause defined as at least 12 months prior to inclusion without menstruation",
"criterion": "post-menopause definition",
"requirements": [
{
"requirement_type": "duration without menstruation",
"expected_value": {
"operator": ">=",
"value": 12,
"unit": "months"
}
}
]
}
]
},
{
"line": "* If female of childbearing potential, MRM should be performed on the 7-14th day of the menstrual cycle.",
"criterions": [
{
"exact_snippets": "If female of childbearing potential",
"criterion": "female of childbearing potential",
"requirements": [
{
"requirement_type": "N/A",
"expected_value": "true"
}
]
},
{
"exact_snippets": "MRM should be performed on the 7-14th day of the menstrual cycle",
"criterion": "MRM timing",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "7-14th day of the menstrual cycle"
}
]
}
]
},
{
"line": "* Has an estimated glomerular filtration rate (eGFR) value >/= 60 mL/min/1.73m^2 derived from a serum creatinine result within 2 weeks prior to study enrollment.",
"criterions": [
{
"exact_snippets": "estimated glomerular filtration rate (eGFR) value >/= 60 mL/min/1.73m^2",
"criterion": "estimated glomerular filtration rate (eGFR)",
"requirements": [
{
"requirement_type": "value",
"expected_value": {
"operator": ">=",
"value": 60,
"unit": "mL/min/1.73m^2"
}
}
]
},
{
"exact_snippets": "serum creatinine result within 2 weeks prior to study enrollment",
"criterion": "serum creatinine result",
"requirements": [
{
"requirement_type": "timeframe",
"expected_value": "within 2 weeks prior to study enrollment"
}
]
}
]
},
{
"line": "Healthy volunteers allowed",
"criterions": [
{
"exact_snippets": "Healthy volunteers allowed",
"criterion": "volunteer health status",
"requirements": [
{
"requirement_type": "status",
"expected_value": "healthy"
}
]
}
]
},
{
"line": "Must have minimum age of 18 Years",
"criterions": [
{
"exact_snippets": "minimum age of 18 Years",
"criterion": "age",
"requirements": [
{
"requirement_type": "minimum",
"expected_value": {
"operator": ">=",
"value": 18,
"unit": "Years"
}
}
]
}
]
}
],
"exclusion_lines": [
{
"line": "* Is a female patient who is pregnant or lactating",
"criterions": [
{
"exact_snippets": "female patient",
"criterion": "gender",
"requirements": [
{
"requirement_type": "presence",
"expected_value": "female"
}
]
},
{
"exact_snippets": "pregnant",
"criterion": "pregnancy status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "lactating",
"criterion": "lactation status",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has any contraindication to the MRM examination (e.g. metal implants, phobia) or the use of gadolinium-containing contrast agents.",
"criterions": [
{
"exact_snippets": "Has any contraindication to the MRM examination (e.g. metal implants, phobia)",
"criterion": "contraindication to the MRM examination",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "contraindication to ... the use of gadolinium-containing contrast agents",
"criterion": "contraindication to the use of gadolinium-containing contrast agents",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
}
]
},
{
"line": "* Has received any contrast agent within 24 hours prior to the study MRM, or is scheduled to receive any contrast agent within 24 hours after the study MRM.",
"criterions": [
{
"exact_snippets": "Has received any contrast agent within 24 hours prior to the study MRM",
"criterion": "contrast agent administration",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within 24 hours prior to the study MRM"
}
]
},
{
"exact_snippets": "is scheduled to receive any contrast agent within 24 hours after the study MRM",
"criterion": "contrast agent administration",
"requirements": [
{
"requirement_type": "time frame",
"expected_value": "within 24 hours after the study MRM"
}
]
}
]
},
{
"line": "* Has severe cardiovascular disease (e.g., known long QT syndrome, acute myocardial infarction [< 14 days], unstable angina, congestive heart failure New York Heart Association class IV) or acute stroke (< 48 hours)).",
"criterions": [
{
"exact_snippets": "severe cardiovascular disease",
"criterion": "severe cardiovascular disease",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "known long QT syndrome",
"criterion": "long QT syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "acute myocardial infarction [< 14 days]",
"criterion": "acute myocardial infarction",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<",
"value": 14,
"unit": "days"
}
}
]
},
{
"exact_snippets": "unstable angina",
"criterion": "unstable angina",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "congestive heart failure New York Heart Association class IV",
"criterion": "congestive heart failure",
"requirements": [
{
"requirement_type": "severity",
"expected_value": "New York Heart Association class IV"
}
]
},
{
"exact_snippets": "acute stroke (< 48 hours)",
"criterion": "acute stroke",
"requirements": [
{
"requirement_type": "time since event",
"expected_value": {
"operator": "<",
"value": 48,
"unit": "hours"
}
}
]
}
]
},
{
"line": "* Has acute renal insufficiency of any severity due to hepato-renal syndrome or in the peri-operative liver transplantation period or who has acute or chronic moderate or severe renal insufficiency (glomerular filtration rate < 60 mL/min/1.73m^2).",
"criterions": [
{
"exact_snippets": "acute renal insufficiency ... due to hepato-renal syndrome",
"criterion": "acute renal insufficiency due to hepato-renal syndrome",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "acute renal insufficiency ... in the peri-operative liver transplantation period",
"criterion": "acute renal insufficiency in the peri-operative liver transplantation period",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "acute ... moderate or severe renal insufficiency",
"criterion": "acute moderate or severe renal insufficiency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "chronic moderate or severe renal insufficiency",
"criterion": "chronic moderate or severe renal insufficiency",
"requirements": [
{
"requirement_type": "presence",
"expected_value": true
}
]
},
{
"exact_snippets": "glomerular filtration rate < 60 mL/min/1.73m^2",
"criterion": "glomerular filtration rate",
"requirements": [
{
"requirement_type": "quantity",
"expected_value": {
"operator": "<",
"value": 60,
"unit": "mL/min/1.73m^2"
}
}
]
}
]
},
{
"line": "* Has received chemotherapy or hormonal therapy for breast cancer within 6 months.",
"criterions": [
{
"exact_snippets": "Has received chemotherapy ... within 6 months.",
"criterion": "chemotherapy for breast cancer",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
},
{
"exact_snippets": "Has received ... hormonal therapy for breast cancer within 6 months.",
"criterion": "hormonal therapy for breast cancer",
"requirements": [
{
"requirement_type": "time since last treatment",
"expected_value": {
"operator": "<=",
"value": 6,
"unit": "months"
}
}
]
}
]
},
{
"line": "* Has received hormone replacement therapy within 4 weeks prior to study drug administration.",
"criterions": [
{
"exact_snippets": "Has received hormone replacement therapy within 4 weeks prior to study drug administration.",
"criterion": "hormone replacement therapy",
"requirements": [
{
"requirement_type": "time since last administration",
"expected_value": {
"operator": "<=",
"value": 4,
"unit": "weeks"
}
}
]
}
]
},
{
"line": "* Is scheduled or likely to require a surgery and/or biopsy in the time period up to 24 hours following study drug application",
"criterions": [
{
"exact_snippets": "scheduled or likely to require a surgery",
"criterion": "surgery requirement",
"requirements": [
{
"requirement_type": "likelihood",
"expected_value": true
}
]
},
{
"exact_snippets": "scheduled or likely to require a ... biopsy",
"criterion": "biopsy requirement",
"requirements": [
{
"requirement_type": "likelihood",
"expected_value": true
}
]
}
]
},
{
"line": "* Has prior excisional biopsy or breast surgery less than 6 months before enrollment and between XRM and study MRM",
"criterions": [
{
"exact_snippets": "prior excisional biopsy or breast surgery",
"criterion": "prior excisional biopsy or breast surgery",
"requirements": [
{
"requirement_type": "timing",
"expected_value": {
"comparisons": [
{
"operator": "<",
"value": 6,
"unit": "months"
}
]
}
}
]
},
{
"exact_snippets": "between XRM and study MRM",
"criterion": "timing of excisional biopsy or breast surgery",
"requirements": [
{
"requirement_type": "timing",
"expected_value": "between XRM and study MRM"
}
]
}
]
}
],
"miscellaneous_lines": [],
"failed_inclusion": [],
"failed_exclusion": [],
"failed_miscellaneous": []
}